HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A phase II study of tegafur plus uracil or tegafur alone for the treatment of advanced hepatocellular carcinoma.

AuthorsClaudio Zavaglia, Cleofe Prisco, Giovambattista Pinzello
JournalEuropean journal of gastroenterology & hepatology (Eur J Gastroenterol Hepatol) Vol. 20 Issue 1 Pg. 87-8 (Jan 2008) ISSN: 0954-691X [Print] England
PMID18090998 (Publication Type: Clinical Trial, Phase II, Letter)
Chemical References
  • Tegafur
  • Uracil
Topics
  • Adolescent
  • Adult
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Carcinoma, Hepatocellular (drug therapy)
  • Female
  • Humans
  • Liver Neoplasms (drug therapy)
  • Male
  • Tegafur (administration & dosage)
  • Uracil (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: